Altesa raises $75M for oral respiratory mednews2026-02-19T12:00:31+00:00February 19th, 2026|Endpoints News|
J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drugnews2026-02-19T11:55:09+00:00February 19th, 2026|Endpoints News|
Why clinical AI startup Kintsugi shut downnews2026-02-18T20:43:12+00:00February 18th, 2026|Endpoints News|
Senate health committee chair plots future FDA changesnews2026-02-18T20:36:22+00:00February 18th, 2026|Endpoints News|
Pharma is done negotiating as Trump pushes to codify dealsnews2026-02-18T20:00:26+00:00February 18th, 2026|Endpoints News|
J&J pours $1B into new cell therapy site in Pennsylvanianews2026-02-18T18:30:40+00:00February 18th, 2026|Endpoints News|
Charles River highlights increase in demand as tariff uncertainties fadenews2026-02-18T17:33:30+00:00February 18th, 2026|Endpoints News|
Updated: Novartis signs macrocyclic deal with Unnatural Productsnews2026-02-18T15:45:20+00:00February 18th, 2026|Endpoints News|
Reversal on Moderna’s flu application follows atypical path through FDAnews2026-02-18T15:45:05+00:00February 18th, 2026|Endpoints News|
Lilly’s Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido resultsnews2026-02-18T15:16:02+00:00February 18th, 2026|Endpoints News|
